Increased dosage of DYRK1A and brain volumetric alterations in a YAC model of partial trisomy 21

Anatomical Record

Volumn 291, Issue 3, 2008, Pages 254-262

  Sebrié, Catherine ^a   Chabert, Caroline ^b   Ledru, Aurélie ^b   Guedj, Fayçal ^b   Po, Chrystelle ^a   Smith, Desmond J ^c   Rubin, Edward ^d   Rivals, Isabelle ^b   Beloeil, Jean Claude ^a   Gillet, Brigitte ^a   Delabar, Jean Maurice ^b  

^a CNRS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d PSL RESEARCH UNIVERSITY   (France)

Author keywords

Brain; Down syndrome; DYRK1A; Magnetic resonance imaging

Indexed keywords

DYRK KINASE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

AGE; AGING; ANIMAL; ARTICLE; BRAIN; DISEASE MODEL; DOWN SYNDROME; ENZYMOLOGY; GENE DOSAGE; GENETICS; GENOTYPE; HUMAN; HYPOTHALAMUS; METABOLISM; MOUSE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOLOGY; PHENOTYPE; THALAMUS; THREE DIMENSIONAL IMAGING; TRANSGENIC MOUSE; UPREGULATION; YEAST ARTIFICIAL CHROMOSOME;

AGE FACTORS; AGING; ANIMALS; ANIMALS, NEWBORN; BRAIN; CHROMOSOMES, ARTIFICIAL, YEAST; DISEASE MODELS, ANIMAL; DOWN SYNDROME; GENE DOSAGE; GENOTYPE; HUMANS; HYPOTHALAMUS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; ORGAN SIZE; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; THALAMUS; UP-REGULATION;

EID: 42149164276     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20640     Document Type: Article

References (22)

1. Ahn KJ, Jeong HK, Choi HS, Ryoo SR, Kim YJ, Goo JS, Choi SY, Han JS, Ha I, Song WJ. 2006. DYRK1A BAC transgenic mice show altered synaptic plasticity with learning and memory defects. Neurobiol Dis 22:463-472.
2. Becker L, Mito T, Takashima S, Onodera K. 1991. Growth and development of the brain in Down syndrome. In: Epstein C, editor. The morphogenesis of Down syndrome. New York: Wiley-Liss. p 133-152.
3. Benavides-Piccione R, Dierssen M, Ballesteros-Yanez I, Martinez de Lagran M, Arbones ML, Fotaki V, DeFelipe J, Elston GN. 2005. Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse. Neurobiol Dis 20:115-122.
4. Branchi I, Bichler Z, Minghetti L, Delabar JM, Malchiodi-Albedi F, Gonzalez MC, Chettouh Z, Nicolini A, Chabert C, Smith DJ, Rubin EM, Migliore-Samour D, Alleva E. 2004. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities and cell cycle protein alteration. J Neuropathol Exp Neurol 63:429-440.
5. Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, Noel B, Sinet PM. 1993. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet 1:114-124.
6. Fotaki V, Dierssen M, Alcantar S, Martine S, Marti E, Casa C, Visa J, Soriano E, Estivil X, Arbones ML. 2002. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol Cell Biol 22:6636-6647.
7. Johnson G, Wadghiri YZ, Turnbull DH. 1999. 2D multislice and 3D MRI sequences are often equally sensitive. Magn Reson Med 41:824-828.
8. Larvaron P, Boespflug-Tanguy O, Renou JP, Bonny JM. 2007. In vivo analysis of the postnatal develoment of normal mouse brain by DTI. NMR Biomed 20:413-421.
9. Paxinos G, Franklin KBJ. 2001. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego: Academic Press.
10. Pinter JD, Eliez S, Schmitt JE, Capone GT, Reiss AL. 2001. Neuroanatomy of Down's syndrome: a high-resolution MRI study. Am J Psychiatry 158:1659-1665.
11. Poissonnier M, Saint-Paul B, Dutrillaux B, Chassaigne M, Gruyer P, de Blignieres-Strouk G. 1976. Partial Trisomy 21 (21q21-21q22.2). Ann Genet 19:69-73.
12. Raz N, Torres IJ, Briggs SD, Spencer WD, Thornton AE, Loken WJ, Gunning FM, McQuain JD, Driesen NR., Acker JD. 1995. Selective neuroanatomic abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45:356-366.
13. Redcay E, Courchesne E. 2005. When is the brain enlarged in autism? A meta-analysis of all brain size reports. Biol Psychiatry 58:1-9.
14. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, Young WG, Bloom FE. 2003. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci U S A 100:1381-1386.
15. Ronan A, Fagan K, Christie L, Conroy J, Nowak NJ, Turner G. 2007. Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region. J Med Genet 44:448-451.
16. Rosen GD, William AG, Capra A, Connoly MT, Cruz B. 2000. The mouse brain library ωww.mbl.org. International Mouse Genome Conference. 14:166.
17. Smith DJ, Stevens ME, Sudanagunta SP, Bronson RT, Makhinson M, Watabe AM, O'Dell TJ, Fung J, Weier HU, Cheng JF, Rubin EM. 1997. Functional screening of 2 Mb of human chromosome 21q22.2 in transgenic mice implicates minibrain in learning defects associated with Down syndrome. Nat Genet 16:28-36.
18. Spittaels K, Van den Haute C, Van Dorpe J, Terwel D, Vandezande K, Lasrado R, Bruynseels K, Irizarry M, Verhoye M, Van Lint J, Vandenheede JR, Ashton D, Mercken M, Loos R, Hyman B, Van der Linden A, Geerts H, Van Leuven F. 2002. Neonatal neuronal overexpression of glycogen synthase kinase-3 beta reduces brain size in transgenic mice. Neuroscience 113:797-808.
19. Turnbull DH, Mori S. 2007. MRI in mouse developmental biology. NMR Biomed 20:265-274.
20. Van Broeck B, Vanhoutte G, Pirici D, Van Dam D, Wils H, Cuijt I, Vennekens K, Zabielski M, Michalik A, Theuns J, De Deyn PP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S. 2006. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiol Aging [epub ahead of print].
21. Weiss C, Venkatasubramanian PN, Aguado AS, Power JM, Tom BC, Li L, Chen KS, Disterhoft JF, Wyrwicz AM. 2002. Impaired eye-blink conditioning and decreased hippocampal volume in PDAPP V717F mice. Neurobiol Dis 11:425-433.
22. Wolf OT, Dyakin V, Patel A, Vadasz C, de Leon MJ, McEwen BS, Bulloch K. 2002. Volumetric structural magnetic resonance imaging (MRI) of the rat hippocampus following kainic acid (KA) treatment. Brain Res 934:87-96.